5th Annual Conference 3D Cell Culture

3D Cell Culture has gained increasing momentum in the pharmaceutical industry over recent years, with the global 3D Cell Culture market predicted to reach a value of $3.2 Billion by 2027, researchers globally are realising the growing potential of in vitro applications for drug discovery, predictivity and validation, safety and toxicity.

Rising demand for tissue engineering for the treatment of chronic diseases is a key driver of this research and new technologies in the form of organ-on-chip, microphysiological systems and 3D bioprinting are all significant emerging areas of the field.

Join us in February 2021, as SMi’s 5th annual 3D Cell Culture Conference brings together industry experts from big pharma, regulatory bodies and the leading biotech companies in the field to discuss the challenges and drivers of the industry, through case studies of the latest innovations in 3D Cell Culture models, real world examples of applications of new technologies and insights into 3D imaging and high throughput screening to give you a comprehensive this fast growing industry.